A Dark Vector Cognition product

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

3K characters. Original on sec.gov · Markdown

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

DIRECTORS OF THE REGISTRANT

The following sets forth certain information regarding our directors as of February 15, 2022, including their name and principal occupation or employment:

Richard T. BurkeF. William McNabb III
Chief Executive Officer and Chair Senior Connect Acquisition Corp.Former Chairman and Chief Executive Officer The Vanguard Group, Inc.
Timothy P. FlynnValerie C. Montgomery Rice, M.D.
Retired Chair KPMG InternationalPresident and Chief Executive Officer Morehouse School of Medicine
Paul. R GarciaJohn H. Noseworthy, M.D.
Retired Chair and Chief Executive Officer Global Payments Inc.Former Chief Executive Officer and President Mayo Clinic
Stephen J. HemsleyGail R. Wilensky, Ph.D.
Chair UnitedHealth GroupSenior Fellow Project HOPE
Michele J. HooperAndrew P. Witty
Lead Independent Director UnitedHealth Group President and Chief Executive Officer The Directors’ CouncilChief Executive Officer UnitedHealth Group

Pursuant to General Instruction G(3) to Form 10-K and the Instruction to Item 401 of Regulation S-K, information regarding our executive officers is provided in Part I, Item 1 under the caption “Information About our Executive Officers.”

We have adopted a code of ethics applicable to our principal executive officer and other senior financial officers, who include our principal financial officer, principal accounting officer, controller and persons performing similar functions. The code of ethics, entitled Code of Conduct: Our Principles of Ethics and Integrity, is posted on our website at www.unitedhealthgroup.com. For information about how to obtain the Code of Conduct, see Part I, Item 1, “Business.” We intend to satisfy the SEC’s disclosure requirements regarding amendments to, or waivers of, the code of ethics for our senior financial officers by posting such information on our website indicated above.

The remaining information required by Items 401, 405, 406 and 407(c)(3), (d)(4) and (d)(5) of Regulation S-K will be included under the headings “Corporate Governance” and “Proposal 1-Election of Directors” in our definitive proxy statement for our 2022 Annual Meeting of Shareholders, and such required information is incorporated herein by reference.

Previous: Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS · Next: Item 11. EXECUTIVE COMPENSATION